Miracalus Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.17 M
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.00 Cr
- Revenue Growth -34.95%
- Profit Growth -1290.28%
- Ebitda -223.96%
- Net Worth -15.11%
- Total Assets -13.25%
About Miracalus Pharma
Miracalus Pharma Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 May 2007 and has a history of 17 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.17 M.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manish Jain and Mohan Jain serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2007PTC171043
- Company No.
171043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Miracalus Pharma Private Limited offer?
Miracalus Pharma Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anesthetic, Digestive System Drugs & Medicines, Antiemetic, Anti Inflammatory Drugs, Anti Cancer Medicines, Erlotinib Tablets, Anticoagulant and Antiplatelet Drugs, Heparin Injection, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Miracalus Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Jain  | Director | 22-May-2007 | Current |
| Manish Jain | Director | 11-Sep-2018 | Current |
Financial Performance of Miracalus Pharma.
Miracalus Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.95% decrease. The company also saw a substantial fall in profitability, with a 1290.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Miracalus Pharma?
In 2023, Miracalus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Mac-Chem Products (India) Private LimitedManish Jain and Mohan Jain are mutual person
Samrudh Pharmaceuticals Private LimitedManish Jain and Mohan Jain are mutual person
Naprod Life Sciences Private LimitedManish Jain and Mohan Jain are mutual person
Medorbis Trade LlpManish Jain and Mohan Jain are mutual person
- Vanquest Pharma Private Limited
Manish Jain and Mohan Jain are mutual person
Charges (Loans)
₹0
₹100.00 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 5.50 Cr
- Icici Bank Limited : 4.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2015 | Bank Of Baroda | ₹5.50 Cr | Satisfied |
| 25 Jul 2011 | Icici Bank Limited | ₹4.50 Cr | Satisfied |
How Many Employees Work at Miracalus Pharma?
Miracalus Pharma has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Miracalus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miracalus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
